INKT
MiNK Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$11.64
+3.65%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
81.0%
Return on equity
-118.1%
Return on assets
88.1%
Return on invested capital
0.00x
Asset turnover
-$2.1B
Cash from operations
$1.73
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026